Prescription Drugs-B - Betaseron - Betaseron 0.3mg Powder Vials 14X1 Each By Bayer Healthcare Pharmaceuticals

Betaseron 0.3mg Powder Vials 14X1 Each By Bayer Healthcare Pharmaceuticals

Betaseron 0.3mg Powder Vials 14X1 Each By Bayer Healthcare Pharmaceuticals Item No.:This Item Requires A Valid Order From A Physician Licensed in USA. RXD4122735 UPC No.: 350419523356 Mfg.Item No.:52335

$ 3189.99
PLEASE PROVIDE US THE NAME, ADDRESS, PHONE #, FAX #, STATE LIC.#, NAME OF STATE, DEA#,AND NPI# OF ORDERING PHYSICIAN. PLEASE PROVIDE ALL INFORMATION AVAILABLE AND ASK YOUR PHYSICIAN TO FAX US THE PRESCRIPTION AT 760-344-6321 FOR THE QUANTITY.
Quantity:

BETASERON is indicated for the treatment of relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and is shown to delay the progression to clinically definite MS (CDMS) when used from the first event suggestive of MS.

BETASERON is a type of protein called interferon.

Interferons occur naturally in the body. They are signaling proteins that the cells in your body use to communicate with one another. Interferons are key communicators in the immune system.

BETASERON is:

  * The only multiple sclerosis treatment that has been available to patients for almost 20 years
  * A pioneer as the first FDA approved disease-modifying therapy for relapsing forms of multiple sclerosis
  * The longest studied multiple sclerosis treatment with over 20 years of clinical and safety data.

mportant Safety Information

  * The most commonly reported adverse reactions are lymphopenia, injection site reaction, asthenia, flu-like symptom complex, headache, and pain
  * Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms
  * BETASERON should be used with caution in patients with depression
  * Injection site necrosis has been reported in 4% of patients in controlled trials
  * Patients should be advised of the importance of rotating injection sites
  * Female patients should be warned about the potential risk to pregnancy
  * Cases of anaphylaxis have been reported rarely
  * See "Warnings, "Precautions," and "Adverse Reactions" sections of the full Prescribing Information

INDICATIONS AND USAGE

BETASERON® (interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
IMPORTANT SAFETY INFORMATION

The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache, and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. BETASERON should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

FREE

shipping*

FREE

gifts

FREE

samples

GET

5% OFF

Click here for Prescribing Information